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The lateral/basolateral amygdala (BLA) forms an integral part of the neural circuitry
controlling innate anxiety and learned fear. More recently, BLA dependent modulation of
self-administration behaviors suggests a much broader role in the regulation of reward
evaluation. To test this, we employed a self-administration paradigm that procedurally
segregates “seeking” (exempliﬁed as lever-press behaviors) from consumption (drinking)
directed at a sweetened ethanol solution. Microinjection of the nonselective serotonin type-
2 receptor agonist, alpha-methyl-5-hydroxytryptamine (α-m5HT) into the BLA reduced lever
pressing behaviors in a dose-dependent fashion. This was associated with a signiﬁcant
reduction in the number of response-bouts expressed during non-reinforced sessions
without altering the size of a bout or the rate of responding. Conversely, intra-BLA α-m5HT
only modestly effected consumption-related behaviors; the highest dose reduced the
total time spent consuming a sweetened ethanol solution but did not inhibit the total
number of licks, number of lick bouts, or amount of solution consumed during a session.
In vitro neurophysiological characterization of BLA synaptic responses showed that α-
m5HT signiﬁcantly reduced extracellular ﬁeld potentials.This was blocked by the 5-HT2A/C
antagonist ketanserin suggesting that 5-HT2-like receptors mediate the behavioral effect
of α-m5HT. During whole-cell patch current-clamp recordings, we subsequently found that
α-m5HT increased action potential threshold and hyperpolarized the resting membrane
potential of BLA pyramidal neurons. Together, our ﬁndings show that the activation of
BLA 5-HT2A/C receptors inhibits behaviors related to reward-seeking by suppressing BLA
principal neuron activity. These data are consistent with the hypothesis that the BLA
modulates reward-related behaviors and provides speciﬁc insight into BLA contributions
during operant self-administration of a sweetened ethanol solution.
Keywords: sipper model, microinjection, alpha-methyl-5-hydroxytryptamine, population spike/field excitatory
postsynaptic potential, ketanserin, whole-cell patch clamp
INTRODUCTION
The amygdala plays a central role in the regulation of risk-
reward valuation. The lateral and basolateral amygdala (BLA)
subdivisions form the primary input nuclei and receive pro-
cessed sensory and executive information from cortical and
subcortical areas (Ottersen, 1982; Brinley-Reed et al., 1995).
Large, pyramidal-shaped BLA principal neurons subsequently
send glutamatergic projections throughout the extended amyg-
dala (De Olmos et al., 1985). These projections help regu-
late the psychological and physiological manifestations of
fear/anxiety. More recent work has shown that BLA pro-
jections to regions like the nucleus accumbens also regu-
late the self-administration of natural rewards (Stuber et al.,
2011) as well as relapse-like drug seeking for cocaine (Las-
seter et al., 2011), heroin (Rizos et al., 2005), and amphetamine
(Rademacher et al., 2010). These data are consistent with the
BLA establishing or evaluating risk-reward relationships and
provide a much broader understanding of amygdala-dependent
behavioral regulation. However, the role of the BLA with
respect to reward-seeking versus consumption, particularly dur-
ing operant self-administration, has not been ﬁrmly estab-
lished.
Samson et al. (1999) developed a self-administration model
that procedurally segregates seeking behaviors from consumption.
In this model, rats are trained to complete an operant response
requirement within a speciﬁc time frame to then gain time-limited
access to a sipper tube connected to a liquid reward (Samson
et al., 1999), most frequently a sucrose and/or ethanol-containing
solution. The seeking (lever press)- and consumption-related
behaviors are thus procedurally separated allowing independent
assessment of their neurobiological mechanisms. Subsequent
work with this model has been somewhat limited but clearly
demonstrates that seeking and consumption are independently
controlled by overlapping but distinct neural circuits and neu-
rotransmitter systems (Czachowski et al., 2001; Samson and
Chappell, 2004; Czachowski, 2005; Henderson and Czachowski,
2011). These ﬁndings are consistent with feeding studies show-
ing independent but integrated neural circuits controlling seeking
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versus intake of food rewards (Pratt and Blackstone, 2009). BLA
contributions to these distinct seeking- and consumption-related
behaviors have never been examined.
In contrast to the largely positive inﬂuence dopaminergic
neurotransmission has on reward seeking and consumption,
serotonergic neurotransmission appears to play a complimen-
tary inhibitory role. For example, increasing serotonin levels
with reuptake inhibitors appears to decrease seeking and/or
self-administration for ethanol (Haraguchi et al., 1990), cocaine
(Burmeister et al., 2003), and amphetamine (Porrino et al., 1989).
Conversely, serotonin depletion increases seeking for both cocaine
(Loh and Roberts, 1990) and natural rewards like food (Roberts
et al., 1994). Thus, serotonergic neurotransmission appears to be
critical for limiting self-administration of both natural and drug
rewards. In particular, Roberts and colleagues implicate seroton-
ergic neurotransmission in the amygdala as being an important
modulator of reward-seeking (Roberts et al., 1994). But, the spe-
ciﬁc neurotransmitter receptors, amygdala subdivisions, cellular
populations, and neurophysiological mechanisms mediating these
effects are largely unexplored.
Serotonin exerts its biological action via the activation of
a heterogeneous collection of receptors that include both het-
erotrimeric G protein-coupled receptors and a ligand-gated ion
channel. mRNAs, protein, or binding activity for the G protein-
coupled 5-HT1 and 2 receptors and their various isoforms are
expressed in the BLA (Bruinvels et al., 1994; Wright et al., 1995;
Li et al., 2003; McDonald and Mascagni, 2007), but their neu-
rophysiological role has not been extensively characterized. BLA
5-HT1A receptors suppress both GABAergic (Koyama et al., 2002)
and glutamatergic synaptic transmission (Cheng et al., 1998). BLA
5-HT2A/C receptors have complex neurophysiological effects and
appear to both stimulate BLA GABAergic interneuron activity
(Rainnie, 1999; Jiang et al., 2009) and may directly inhibit BLA
principal neurons (Rainnie, 1999) though the precise mechanisms
governing this latter effect need to be better understood. Further,
the precise behavioral roles these different BLA receptors play in
the modulation of operant self-administration is not currently
clear.
In the present work, we have used a self-administration
paradigm that procedurally segregates seeking and consumption
to examine the role of the BLA in modulating these indepen-
dent behavioral components. We integrate this approach with
direct BLA microinjection of a 5-HT2-selective agonist. These
behavioral approaches are complimented by in vitro investigation
of the neurophysiological impact of this agonist. Our ﬁndings
provide strong support for the notion that BLA neuron activity
is critical for the regulation of reward seeking-related behaviors
and highlights potential cellular mechanisms that mediate these
outcomes.
MATERIALS AND METHODS
ANIMAL SUBJECTS
Adult male Long-Evans rats (250 g) were purchased from Har-
lan (Indianapolis, IN, USA). Animals were subjected to handling
and behavioral manipulations according to the NIH Guide for
the Care and Use of Research Animals. All procedures were
approved by the Wake Forest Medical School IACUC. Animals
were individually housed on a standard 12 h light/dark cycle (6
am lights on) with food and water ad libitum except during the
2-h self-administration sessions (below).
OPERANT SELF-ADMINISTRATION
All experiments were performed in sound-attenuated operant
chambers (Med Associates, St. Albans, Vermont, USA) equipped
with house lights, fans, operant levers, and sipper tubes as
described previously (McCool andChappell, 2009). Commercially
available software (MedPC, Med Associates) controlled access to
levers and sipper tube access. Three days prior to operant train-
ing, animals were given an initial forced exposure to 10% ethanol
in the home cage during which time ethanol was the only liquid
available as described (Samson et al., 2001). During this period,
animals consumed 5.3 ± 0.2 g/kg ethanol per day. The subse-
quent operant training consisted of an initial 4 h session when rats
(n = 9) were trained with an FR1 schedule that provided 40 s of
access to sipper tubes containing a 10% sucrose solution in water.
Over the next week, we gradually decreased session time and grad-
ually increased the ﬁxed ratio schedule and sipper tube access time
until daily sessions consisted of a single 20 min period to fulﬁll the
desired response requirement (RR) followed by a single 20 min
sipper tube access-period. This operational segregation of lever-
press and drinking periods allowed independent measurement
of “seeking” and “consuming” behaviors (Samson et al., 2001).
Self-administration sessions started 1 h after lights-on and ran
5 days each week until the end of the microinjections. Over several
weeks, we increased response requirements and gradually lowered
the sucrose concentration/increased ethanol concentration in the
sipper until animals had to fulﬁll a RR30 to access as solution con-
taining 2% sucrose/10% ethanol. We utilized sweetened ethanol
to avoid potential confounds related to food- versus drug-rewards
(Czachowski, 2005). Eight out of nine individuals consistently
executed the RR30 for sucrose/ethanol and were included in the
microinjection experiments (below). Following 2 weeks of stable
responding, we subjected animals to bi-weekly, single-day “non-
reinforced” sessions where levers were available but sipper tubes
did not lower into the self-administration chamber. Normal RR30
reinforced sessions surrounded these “seeking” sessions the other
4 days on these weeks. Previous work has shown that, under
this schedule, individual “non-reinforced” sessions produce sta-
ble lever press behaviors that do not extinguish across many weeks
(Samson et al., 2001). Data from these two sessions were pooled
and served as baseline “seeking” behaviors. Ethanol consumption
levels during the training and baseline periods when animals were
all consuming 2% sucrose/10% ethanol were 1.09 ± 0.07 g/kg per
session. Ethanol intakes dropped to 0.94±0.05 g/kgper session the
week following the stereotaxic surgeries (see below) and remained
in this range for the remainder of the study (see Table 2).
SURGERIES AND MICROINJECTIONS
Following the operant training period, animals were deeply
anesthetized with pentobarbital (50 mg/kg, IP), attached to a
stereotaxic frame (Kopf Instruments, Tujunga, CA, USA), and
ﬁt with chronic 26 gage guide cannula directed at the ventral
aspect of the lateral amygdala [–2.80 mm from bregma; medio-
lateral, from the midline +5.05 mm; ventral from the top of the
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Table 1 | Responding-related behaviors across the microinjection
period during non-experimental days.
Response
latency (s)2
Press rate
(#/min)
Press time
(min)
Week 1 54.3 ± 21.9 20.4 ± 6.6 4.3 ± 1.9
Week 21 53.8 ± 14.1 21.0 ± 7.0 3.9 ± 1.2
Week 3 40.5 ± 6.3 24.4 ± 10.0 3.4 ± 1.3
Week 4 47.8 ± 12.5 18.7 ± 5.3 3.5 ± 1.2
Week 5 76.9 ± 19.7 24.2 ± 5.7 2.6 ± 0.9
Week 6 66.8 ± 9.6 30.4 ± 7.1 2.3 ± 0.8
Week 7 46.7 ± 16.3 25.5 ± 5.6 2.7 ± 1.1
10.02 μg α-methyl 5-HT was microinjected on weeks 2–3, 0.2 μg on weeks
4–5, and 2.0 μg on weeks 6–7. Values listed here represent pressing during non-
injection days. Repeated measures ANOVA did not identify any signiﬁcant effect
of week across the parameters listed.
2Mean weekly values were calculated using data from Monday,Tuesday, and Fri-
day from the week just after surgery and on injection weeks (see Materials and
Methods). Values are reported as mean ± SEM (n = 8).
brain, –6.20 mm; (McCool and Chappell, 2007)]. At the time of
surgery, rats weighed 472 ± 14 g. Rats recovered over the weekend
and returned to the self-administration chambers the following
week. They gained weight throughout the course of the exper-
iment (ﬁnal body weight = 529 ± 18 g). Daily post-surgical
handling included manipulation of the cannula obturator and
exposure to microinjection pump noise. On microinjection days,
Hamilton syringes delivered 0.5 μl of sterile alpha-methyl-5HT
in artiﬁcial cerebrospinal ﬂuid (see below) over 1 min through
33 gage injection cannula that extended 1.0 mm ventral from
the end of the guide cannula. We left injection cannula in place
for an additional minute before animals were placed into the
self-administration chamber. Seeking- and consumption-related
behaviors were probed on alternate weeks by microinjection of
a single dose of α-m5HT prior to either a single non-reinforced
session (above) or a standard self-administration session. Doses
of α-m5HT were tested in an ascending series. At the end of the
microinjection experiments, animals were euthanized; and brains
were ﬁxed with paraformaldehyde for post-mortem determina-
tion of cannula placement. Cannulas were placed in the target
region (Figure 1A) in all animals included in this report. In one
animal, cannulas were placed posterior of the BLA into the ven-
tral aspect of the hippocampus (CA1). This animal was excluded
from our analysis; but α-m5HT did not appear to produce any
dose-dependent behavioral effects in this one subject.
DRUGS
Alpha-methyl-5-hydroxytryptamine (α-m5HT)maleate, ketanserin
tartrate, and bicuculline methiodide were purchased from Tocris
Cookson (Ellisville, MO, USA). Ethanol (95%) was purchased
from Warner–Graham Company (Cockeysville, MD, USA).
Sucrose and salts used in the electrophysiology experiments were
all purchased from Sigma–Aldrich (St. Louis, MO, USA).
IN VITRO ELECTROPHYSIOLOGY
Basolateral amygdala extracellular synaptic responses and princi-
pal neuron activity were measured ex vivo in coronal brain slices
prepared from adult male rats (Harlan) according to established
procedures (Christian et al., 2013). Slices were allowed to recover
for 1hr and then continuously perfused (2 ml/min) with artiﬁ-
cial cerebrospinal ﬂuid within a custom-built submersion-type
recording chamber.
For extracellular ﬁeld potential experiments, recording elec-
trodes containing 0.9% saline measured synaptically driven“ﬁeld”
population spikes/excitatory postsynaptic potentials (PS-EPSP)
evoked with a bipolar stimulating electrode placed along the lat-
eral boundary of the lateral/basolateral amygdala as previously
described (Lack et al., 2009). Previous work has shown this PS-
EPSP is inhibited both by the voltage-gated sodium channel
antagonist tetrodotoxin and by the ionotropic glutamate receptor
antagonist DNQX (Lack et al., 2008; Lack et al., 2009). Stimulus
Table 2 | Consumption-related behaviors across the microinjection period during non-experimental days.
Licks/session2 Amount consumed
(mL)
Ethanol consumed
(g/kg)
Lick bouts3
Week 1 839 ± 81 5.6 ± 0.5 0.91 ± 0.08 3.5 ± 0.8
Week 21 889 ± 88 5.9 ± 0.5 0.92 ± 0.07 3.7 ± 1.0
Week 3 968 ± 106 6.1 ± 0.6 1.0 ± 0.08 3.8 ± 1.0
Week 4 980 ± 88 6.3 ± 0.6 0.99 ± 0.07 3.4 ± 1.1
Week 5 1123 ± 179 6.2 ± 0.5 0.95 ± 0.06 4.2 ± 1.2
Week 6 955 ± 159 5.8 ± 0.4 0.88 ± 0.06 4.4 ± 1.7
Week 7 810 ± 133 5.5 ± 0.5 0.83 ± 0.07 4.3 ± 1.4
10.02 μg α-methyl 5-HT was microinjected on weeks 2–3, 0.2 μg on weeks 4–5, and 2.0 μg on weeks 6–7. Values here represent drinking parameters expressed
during non-microinjection days. Repeated measures ANOVA did not identify any signiﬁcant effect of week across the parameters listed.
2Mean weekly values were calculated using data from Monday, Tuesday, and Friday from the week just after surgery and on injection weeks (see Materials and
Methods). Values are reported as mean ± SEM (n = 8).
3A lick bout is deﬁned as continuous touches on the sipper spout without a pause in drinking longer than 20 s.
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FIGURE 1 | Intra-BLA α-methy-5HT reduces seeking-like behaviors during
non-reinforced self-administration sessions by reducing the total
number of lever-pressing bouts. (A) Representation of guide cannulae
placements for the microinjection experiments. Figures are taken from
Paxinos andWatson (Paxinos andWatson, 2005); numbers on the right
correspond to the rostral/caudal coordinates of the coronal sections relative to
Bregma. Relative placement of guide cannulae tips are indicated by the black
circles (•). Injection cannulae would have extended ∼0.5 mm below the guide
cannulae. (B) Exemplars of lever-pressing behaviors from a single individual
illustrating the effects microinjection of increasing doses of α-m5HT.
Horizontal portions of the curves represent periods with no lever pressing.
Vertical deﬂections represent the number of lever presses during a particular
bout (here deﬁned as continuous lever presses without a pause greater than
20 s). (C) Summarized data from the entire experimental group shows that
intra-BLA α-m5HT signiﬁcantly reduces (P < 0.05, repeated measures
ANOVA) the total number of lever presses that occur during non-reinforced
self-administration sessions. *P < 0.05 compared to pre-surgical baseline
using Neuman–Keuls multiple comparisons post hoc test. (D) Intra-BLA
α-m5HT reduces the total number of lever pressing bouts during
non-reinforced sessions in a dose-dependent fashion. Repeated-measures
ANOVA indicated signiﬁcant differences (P < 0.001) between pre-surgical
baseline and all the doses of α-m5HT used in our study. ∗P < 0.05,
∗∗P < 0.01, and ∗∗∗P < 0.001 compared to baseline (Neuman–Keuls
post-test). #P < 0.05 compared to the 0.02 μg dose (Neuman–Keuls). (E)The
effect of α-m5HT on lever pressing during non-reinforced sessions was not
related to changes in the average number of lever presses during individual
bouts (bout size). (F)The average number of lever pressing bouts during
reinforced sessions (response requirement = 30, see Materials and Methods)
on non-microinjection days was stable during the time-frame of the
microinjection experiments. There were no signiﬁcant effects of “week”
across the experiment (repeated measures ANOVA). The doses delivered
during these weeks are indicated in brackets. Additional parameters
measured during the reinforced sessions (non-microinjection days) are found
inTable 1.
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intensity was adjusted in each slice so that the PS-EPSP ampli-
tude was ∼70% of maximum. In experiments were the effects of
the 5-HT2or GABAA antagonist were measured, slices were pre-
incubated in antagonists prior to establishing thePS-EPSPbaseline
response and subsequentlymeasuring the effect of α-m5HT. These
data are therefore expressed as a percent effect and statistically
compared to the non-antagonist condition.
Whole-cell current clamp recordings used an intracellular
recording solution consisting of (in mM) 140 K-gluconate, 10
HEPES, 5 NaCl, 1 EGTA, 0.1 CaCl2, 2 Mg-ATP, 0.3 Na2-GTP, pH
7.2 with gluconic acid, 290 mmol/kg osmolality. Principal neurons
were identiﬁed in the whole-cell conﬁguration by their electri-
cal properties including a large whole-cell capacitance, passive
membrane properties, and action potential response to prolonged
depolarizations (Rainnie et al., 1993).
Commercially available software (pClamp10.0, Molecular
Devices, Sunnyvale, CA, USA) collected responses in current-
clamp mode (Axoclamp 200B or Multiclamp 700B, Molecular
Devices). Calibrated syringe pumps delivered α-m5HTto the
recording chamber at a rate of 0.1ml/min to produce the indicated
ﬁnal concentration. Concentration-effect curves were generated
using an ascending concentration series. All recordings were car-
ried out at room temperature. PS-EPSP peak (mV) and slope
(mV/ms; calculated from the 20–80% rise time of the response
measured from baseline to the peak of the response) and action
potential threshold (mV) were measured ofﬂine.
STATISTICAL ANALYSIS
For the microinjection experiments, we utilized a within-subject
design to increase statistical power; these data were analyzed with
repeated-measures one-way ANOVA and comparisons between
drug doses and control values were made with Neuman–
Keuls multiple-comparison post-test. Only signiﬁcant differences
between speciﬁc drug doses and control values are illustrated in the
ﬁgures. Signiﬁcant main-effects and comparisons between doses
are discussed in the text. P values < 0.05 for both main-effect
and post-test were considered signiﬁcant. For the electrophysiol-
ogy experiments, across-treatment comparisons were performed
using standard one-way ANOVA and Neuman–Keuls multiple
comparison post-tests or paired t-test as appropriate. P < 0.05
was considered signiﬁcant in both cases.
RESULTS
INTRA-BLA α-METHYL-5HT SUPPRESSES OPERANT
SUCROSE/ETHANOL SELF-ADMINISTRATION
We trained animals to lever press on a RR30 to gain 20 min access
to a sweetened ethanol solution (2% sucrose/10% ethanol). Both
lever responding- (Table 1) and consumption-related behaviors
(Table 2) were stable on non-injection days throughout the time
span of the microinjection experiments. This conﬁrms previous
ﬁndings (Samson et al., 2001) showing that the intermittent “non-
reinforced” sessions used to assay seeking-like (e.g., lever press
only) behaviors did not disrupt or extinguish normal operant
behaviors.
Lever-press behaviors related to reward seekingwere speciﬁcally
measured during non-reinforced sessions where lever presses did
not lead to presentation of the sweetened ethanol/sucrosemixture.
Lever-press behaviors expressed during these non-reinforced ses-
sions are stable for up to 7 weeks (i.e., do not extinguish) when
they are separated by standard operant sessions where lever presses
are reinforced with reward (Samson et al., 2001). These non-
reinforced trials were speciﬁcally used to measure lever press
behaviors (seeking) without potential confounds arising from the
pharmacological effects of ethanol. During these non-reinforced
sessions, we found that α-m5HT microinjection into the BLA sig-
niﬁcantly reduced the total number of non-reinforced lever presses
(Figures 1B,C; P < 0.05, repeated measures ANOVA, F = 3.2,
df = 7) with signiﬁcant differences between the 2.0 μg dose and
pre-surgery baseline (P < 0.05, Neuman–Keuls multiple compar-
ison post-test). This dose-dependent reduction of non-reinforced
responding was accompanied by a signiﬁcant reduction in the
total number of lever pressing bouts, where a bout is deﬁned
as lever pressing without any pause greater than 20 s (Samson
et al., 2000), relative to the number of bouts expressed during
pre-surgery baseline (Figure 1E; P < 0.001, F = 13.2, repeated
measures ANOVA) at both the 0.2 and 2.0 μg doses (P < 0.01 and
P< 0.001, respectively,Neuman–Keulsmultiple comparison post-
test). These effects were not due to any signiﬁcant decrease in the
size of individual lever pressing bouts expressed during the session
(presses/bout; Figure 1D; P > 0.05, F = 0.5, repeated measures
ANOVA) or any decrease in the total time spent responding during
the session relative to control (not shown; CON = 13.5 ± 1.0 min,
0.02 μg dose = 12.0 ± 2.4 min, 0.2 mg dose = 12.3 ± 2.7 min,
2.0 μg dose = 6.6 ± 2.0 min, P > 0.05, F = 2.6, repeated
measures ANOVA). But, the latency to begin responding during
these non-reinforced“seeking”sessions was signiﬁcantly increased
(P < 0.001, F = 10.4) by BLA microinjection of the α-m5HT
2.0 mg dose (54.0 ± 9.9 s for baseline, 90.4 ± 18.0 s for 0.02 μg,
29.5 ± 10.7 s for 0.2 μg, and 123.7 ± 19.8 s for 2.0 μg; P < 0.01
for the later dose compared to pre-surgery). Finally, intra-BLA
administration of α-m5HT did not signiﬁcantly alter response
rates (number of lever presses per second) during non-reinforced
sessions (main effect P> 0.05, F = 1.5). To examine whether these
various lever-press behaviors were stable throughout the same
experimental time-frame as the microinjection experiments, we
examined the standard operant sessions surrounding the non-
reinforced, microinjection days. The number of bouts during
these regular self-administration sessions (with RR30) did not
vary across any doses (Figure 1F; main effect P > 0.05, F = 2.6,
repeated measures ANOVA). Similarly, response latency, response
rate, and total response time did not signiﬁcantly vary across the
entire microinjection period (Table 1). These ﬁndings show that
intra-BLA α-m5HT signiﬁcantly decreases seeking-related behav-
iors directed at a sweetened ethanol solution by decreasing the total
number of lever pressing bouts during a session and by increasing
the latency to begin lever pressing once the sessions begin.
In contrast with the intra-BLA α-m5HT suppression of lever
responding during non-reinforced sessions, the 5-HT2 agonist
did not appear to signiﬁcantly alter most of the consumption-
related behaviors in this self-administration paradigm. Neither the
total number of licks directed at the sweetened ethanol solution
(Figures 2A,B; P > 0.05, F = 0.4) nor the number of licking bouts
(continuous licking without a 20 s pause; Figures 2C,D; P > 0.05,
F = 0.4) were altered by any of the α-m5HT doses. However,
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FIGURE 2 | Intra-BLA α-m5HT has modest effects on consumption
related behaviors during self-administration of a sweetened ethanol
solution. (A) Exemplar drinking behaviors expressed by a single animal
during self-administration sessions recorded following microinjection of the
indicated doses. Vertical deﬂections indicate continuous licking (no pause
greater than 20 s) of a sipper tube containing 2% sucrose/10% ethanol.
Horizontal deﬂections show periods with no drinking. (B) The total number
of sipper tube licks during the 20 min self administration period was not
altered by microinjection of α-m5HT. There was no signiﬁcant difference
between pre-surgical baseline and any dose (P > 0.05, F = 0.4, repeated
measures ANOVA). (C) Intra-BLA microinjection of α-m5HT did not alter the
total number of lick bouts, deﬁned as continuous licking of the sipper tube
without a break greater than 20 s. There was no signiﬁcant difference
between pre-surgical baseline and any dose of α-m5HT (P > 0.05, F = 0.5,
repeated measures ANOVA). (D) The mean number of licks per bout was
not signiﬁcantly altered by intra-BLA α-m5HT (P > 0.05, F = 1.0, repeated
measures ANOVA). (E) Microinjection of 2 μg α-m5HT signiﬁcantly
decreased (P < 0.05, F = 4.9, repeated measures) the amount of time
animals spent licking (“Lick time”) relative to both the pre-surgery baseline
and the 0.2 μg dose. ∗P < 0.05 compared to pre-surgery baseline,
@P < 0.05 compared to 0.2 μg dose, Neuman–Keuls multiple comparison
post-test. (F) The time animals spent licking the sipper tube during the
20 min access period was stable across the entire time-frame of the
microinjection experiments. There were no signiﬁcant effects of “week”
across the experiment (repeated measures ANOVA). The doses delivered
during experimental days of these weeks are indicated in brackets.
Additional drinking parameters measured during non-experimental days are
found in Table 2.
we did ﬁnd that the time spent licking the sipper tube was sig-
niﬁcantly reduced by BLA α-m5HTmicroinjections at the highest
dose (Figure 2E; main effect P< 0.05, F = 4.9); and, there was also
a main effect of treatment on session lick rates (CON = 159 ± 22
licks/min, 0.02 μg = 290 ± 75 licks/min, 0.2 μg = 126 ± 38
licks/min, 2.0 mg = 250 ± 62 licks/min; P < 0.05, F = 3.3)
but post-tests did not identify any signiﬁcant differences between
speciﬁc doses. Lick times (Figure 2F), lick rates (not shown),
and other consumption-related variables were stable on non-
microinjection days across this same time period (Table 2). These
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ﬁndings appear consistent with a modest α-m5HT-dependent
modulation of some drinking-related dependent variables
(lick rate and lick time) but these effects were not dose-
dependent.
α-METHYL-5HT INHIBITS BLA FIELD RESPONSES IN VITRO
To understand the neurophysiological mechanism mediating the
behavioral effects of α-m5HT microinjection into the BLA, we
recorded population spikes-extracellular EPSPs (PS-EPSP) from
coronal brain slices containing the BLA. We found that α-m5HT
inhibited BLA PS-EPSPs in a concentration dependent manner
(Figures 3A,B). To standardize the concentration-effect curve
across slices, we normalized the effect of each concentration
to the percent inhibition in the presence of 30 μM α-m5HT
which appeared to be maximally efﬁcacious in all the slices exam-
ined in this study. The effect of α-m5HT on the PS-EPSP slope
(EC50 = 3.2 ± 1.2 μM, n = 7) was signiﬁcantly more potent
than on the peak of the response (EC50 = 4.6 ± 0.7 μM;
P < 0.05, paired t-test). For the lower concentrations of α-m5HT
(≤10 μM), inhibition was readily reversible during drug wash-out
(Figure 3C). Although the concentration-response relationship
suggests there might be some tachyphylaxis during the ascend-
ing concentration experimental design, there were no signiﬁcant
differences between the magnitude of PS-EPSP inhibition with
the two highest concentrations (30 and 100 μM; P > 0.05, paired
t-test).
To further reﬁne the mechanisms responsible for modula-
tion of the BLA PS-EPSP, we pretreated slices with ketanserin
(20 μM), a 5-HT2A/C receptor antagonist, prior to exposure with
10 μM α-m5HT. Ketanserin signiﬁcantly reduced α-m5HT inhi-
bition of the BLA PS-EPSP response peak (Figure 3D; n = 3,
P < 0.05 and F = 5.8) relative to the agonist alone (n = 10).
These data suggest that 5HT2-like receptors mediate the neuro-
physiological effects of α-m5HT. The literature also suggests that
5HT2 receptors may facilitate BLA GABAergic function (Rainnie,
1999; Jiang et al., 2009); and this could be a potential mechanism
governing α-m5HT-mediated suppression of the BLA PS-EPSP.
However, pretreatment of BLA slices with the GABAA receptor
antagonist bicuculline (10 μM, n = 11) did not signiﬁcantly
alter α-m5HT modulation of the PS-EPSP (Figure 3D). These
ﬁndings suggest that GABAA receptor-mediated responses did not
contribute signiﬁcantly to α-m5HT inhibition of the ﬁeld EPSP
amplitude or slope.
α-METHYL-5HT SUPPRESSES THE BLA PRINCIPAL NEURON
EXCITABILITY
Previous studies have shown that 5-HT2A/C receptors do not
appear to modulate glutamatergic synapses in this brain region
(Cheng et al., 1998). Our PS-EPSP ﬁndings show that the GABAA
antagonist bicuculline does not diminish α-m5HT modulation
of BLA PS-EPSP suggesting that additional mechanisms may be
important. We subsequently performed whole-cell current clamp
recordings of BLA principal neurons to test the effects of the
5-HT2A/C agonist on excitability.We found thatα-m5HT reduced
the number of action potentials generated at moderate membrane
depolarizations (Figure 4A). This was accompanied by a small
but statistically signiﬁcant hyperpolarization of the membrane
potential from −60.5 ± 1.1 to −61.7 ± 1.2 mV (Figure 4B;
P < 0.05 paired t-test, n = 6) as well as by an agonist-dependent
increase in themembranepotential required to reach actionpoten-
tial threshold from −38.0 ± 1.6 to −31.7 ± 2.4 mV (Figure 4C;
P< 0.05, paired t-test). This increase in action potential threshold
was also accompanied by an α-m5HT-dependent broadening of
the action potential, with area increasing from 280.3 ± 11.9 to
339.3 ± 29.4 mV × ms; but this effect did not reach statistical
signiﬁcant (not shown, P < 0.1, paired t-test). α-m5HT did not
diminish the maximal number of action potentials that could be
generated during a prolonged/strong depolarization (not shown)
nor did it signiﬁcantly alter the membrane response to a hyper-
polarizing current injection (Figure 4D; P > 0.05, paired t-test).
These data suggest that the 5HT2A/C-mediated inhibition of the
BLA PS-EPSP is at least partially mediated by direct inhibition
of BLA neuron excitability via an increase in action potential
threshold.
DISCUSSION
Microinjection of α-m5HT into the BLA prior to operant self-
administration of a sweetened ethanol solution dramatically
decreased the total number of responses during a non-reinforced
“seeking” session. This inhibition of seeking is characterized by
a signiﬁcant decrease in the total number of responding bouts
(continuous lever pressing without a pause > 20 s) without any
alteration of the number of lever-presses per individual bout.
These characteristics suggest that intra-BLA α-m5HT interferes
with the initiation of a response bout rather than the processes
that govern duration of a response bout once it has began. We
cannot directly rule out α-m5HT-induced suppression of locomo-
tor activity as potentially contributing to decreased lever-pressing
behaviors. However, the selective effects on lever-pressing ver-
sus consumption (see below) suggest α-m5HT was not markedly
sedating. Previous work has also shown that intra-BLA adminis-
tration of a 5HT2 agonist does not affect closed-arm entries in the
elevated plus maze (Cornelio and Nunes-de-Souza, 2007) and that
intra-BLA depletion of serotonin had no impact on the total num-
ber of arm in this same assay (Sommer et al., 2001). Both measures
have been consistently used in the literature as indirect indicators
of locomotor behavior. This suggests that locomotor impairment
may not be a signiﬁcant contributor to the effects of α-m5HT on
lever pressing behaviors.
Although the procedural separation of seeking- and drinking-
behaviors is not common in the literature, work from the labs
of Dr. Hank Samson and Dr. Cristine Czachowski permit some
comparisons between BLA-dependent effects on lever pressing
and other brain regions. For example, microinjection of the
D2 dopamine receptor antagonist raclopride into the nucleus
accumbens increased the latency to respond in non-reinforced
sessions and also decreased the number of responses during
these sessions (Czachowski et al., 2001; Samson and Chappell,
2004). Serotonin type 1B receptors in the nucleus accumbens
also modulate seeking behaviors during non-reinforced sessions
in animals trained to self-administer both sucrose and ethanol
(Czachowski, 2005). These studies, together with our ﬁndings,
support recent work illustrating the importance of the BLA-
accumbens circuit during cue-induced responding (Ishikawa et al.,
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FIGURE 3 | α-m5HT inhibits BLA extracellular responses to synaptic
stimulation via 5-HT2 receptors. (A) Exemplar population
spikes/excitatory postsynaptic potentials (PS-EPSP) evoked by stimulation
of the external capsule. These extracellular responses were recorded in the
BLA using an in vitro coronal brain slice preparation. Arrow denotes
position of the stimulation artifact that has been removed for clarity. Note
that 30 μM α-m5HT suppresses both the amplitude and the slope of the
negative deﬂection that represents the BLA PS-EPSP. (B) Concentration-
effect curves for PS-EPSP modulation by α-m5HT show that EC50 values
for PS-EPSP amplitude slope (mV/ms, open circles) and amplitude (mV,
closed circles) are distinct (P < 0.05, paired t -test). Data were normalized
to the percent inhibition by 30 μM in each slice to reduce slice-to-slice
variance in α-m5HT efﬁcacy. (C) Time course of α-m5HT modulation of BLA
PS-EPSP slope indicate that modulation has a rapid onset and can reverse
during prolonged washout of the drug. PS-EPSP modulation appeared less
robust and washed out faster with 10 μM α-m5HT (closed circles)
compared to 30 μM α-m5HT (open circles). (D) Pharmacological analysis of
α-m5HT modulation (10 μM) suggests that inhibition of the BLA PS-EPSP is
mediated by 5-HT2 receptors but does not involve activation of
GABAA-dependent signaling. Compared to α-m5HT modulation of the
PS-EPSP alone (n = 10), the modulation of PS-EPSP peak amplitude and
slope was signiﬁcantly attenuated by 20 μM ketanserin (P < 0.05 and
F = 5.8 for peak, P < 0.05 and F = 4.5 for slope, one way ANOVA, n = 3)
but was not altered by the GABAA receptor antagonist bicuculline (10 μM,
n = 11). *P < 0.05 compared to control from Neuman–Keuls multiple
comparison post-test.
2008; Stuber et al., 2011) and emphasize that this circuit can reg-
ulate the “seeking” aspects of some operant behaviors. While
the precise mechanism remains to be established in the context
of the current operant paradigm, BLA modulation risk/reward-
related decision-making (Ghods-Shariﬁ et al., 2009; Zeeb and
Winstanley, 2011) and reward valuation (Shiﬂett and Balleine,
2010; Wassum et al., 2011) are both possible means by which
BLA-dependent neurophysiology might regulate reward-seeking
behaviors.
Compared to seeking behaviors, the effects of intra-BLA
α-m5HT on drinking-related behaviors were more modest. Only
the highest dose tested decreased the total amount of time ani-
mals spent licking the sweetened ethanol solution without any
signiﬁcant changes to the number of licks, lick bouts, or lick
bout size. Since the total number of licks per session wasn’t
altered by intra-BLA α-m5HT, the modest, non-signiﬁcant effects
on both the total number of lick bouts and the mean size of
the lick bouts must have together summed to reduce the total
time animals spent consuming the sweetened-ethanol solution.
The BLA also modulates operant responding for food pellets
but does not disrupt free-feeding in rats (Simmons and Neill,
2009). These ﬁndings suggest that the BLA exerts control over
the “learned” seeking-consumption associations inherent within
many operant paradigms. Regardless, the modest effects of intra-
BLA α-m5HT on ethanol/sucrose consumption are very similar
to the modest effects of intra-nucleus accumbens raclopride on
ethanol drinking when employing the same model (Czachowski
et al., 2001; Samson and Chappell, 2004). This nucleus accumbens
serotonin system work also suggests that modulation of seeking
and drinking behaviors may depend upon whether ethanol or
sucrose is used as the reward (Czachowski, 2005). Reward-speciﬁc
modulation in an operant setting appears to also generalize for
limited-access to sucrose and ethanol in the home cage (Strat-
ford and Wirtshafter, 2011). Since BLA-to-nucleus accumbens
glutamatergic inputs convey primarily reward-related informa-
tion (Pratt and Mizumori, 1998; Stuber et al., 2011), these data
could suggest that modulation of the BLA by α-m5HT would
be expected to inﬂuence primarily reward-seeking. But future
comparisons between seeking/consuming behaviors directed at
distinct rewards might help identify speciﬁc contributions by the
BLA to these distinct but overlapping behavior outcomes in the
operant setting.
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Although the current study focused on ethanol-directed oper-
ant behaviors, the literature suggests that 5-HT2 receptors reg-
ulate many types of reward. For example, ketanserin modulates
responding for food in both non-human primates (Brady and
Barrett, 1985) and rodents (Higgins et al., 2013). 5-HT2 receptors
can also modulate the discriminative and locomotor stimulant
effects of both cocaine and nicotine in rodents (McMahon and
Cunningham, 2001; Hayes et al., 2009; Nic Dhonnchadha et al.,
2009; Higgins et al., 2013). In apparent contrast to these ﬁnd-
ings, Maurel et al. (1999) showed that 5-HT2 agonists speciﬁcally
disrupt ethanol- but not water-directed operant behaviors in
water-sated rats using a two-lever choice operant paradigm. Simi-
larly, 5HT2 agonists disrupt reinstatement of operant responding
for cocaine- but not sucrose-associated cues in food-sated animals
(Burbassi and Cervo, 2008; Nic Dhonnchadha et al., 2009). These
data together suggest that reward value may be critically impor-
tant for 5HT2 receptor-mediated effects on operant behaviors.
How might 5HT2-like receptors be involved in the recognition
or reward value? These receptors modulate a complex array of
animal behaviors in various models including anxiety (Kennett
et al., 1994), impulsivity (Hadamitzky et al., 2009), and work-
ing memory (Terry et al., 2005). And BLA 5-HT2-like receptors
speciﬁcally regulate anxiety-like behaviors (Zangrossi and Gra-
eff, 1994), impulsive decision making (Hadamitzky and Koch,
2009), and conditioned aversion (Macedo et al., 2007). Given that
acute ethanol is often considered an aversive stimulus in naïve
animals (Phillips et al., 2005), complex interactions between anx-
iety, impulsive decision making, and conditioned behaviors may
drive BLA-dependent modulation of operant behaviors directed
at either drug or natural rewards. We should note that we
cannot exclude potential effects of the self-administration pro-
cedure itself on BLA 5-HT2-like receptor expression or function.
However, previous work using robust, non-contingent ethanol
exposure (Ulrichsen, 1991; Pandey et al., 1992) or home-cage self-
administration (Korpi et al., 1992) found very little impact on
either receptor binding and/or signal transduction. Regardless,
our data are consistent with the hypothesis that BLA 5-HT2-like
receptorsmay be speciﬁcally involvedwith risk/reward evaluations
in the context of operant self-administration. The current study
also integrated behavioral studies with in vitro electrophysiology
FIGURE 4 | α-methyl-5HT suppresses BLA principal neuron excitability
via increasing threshold for action potential initiation. (A) Exemplar
traces illustrating the decrease in excitability following α-m5HT application in
a BLA principal neuron. The traces were generated with identical
hyperpolarizing and depolarizing current injections under control (standard
aCSF) and ∼10 min after drug treatment. Calibration bars: x = 10 ms,
y = 10 mV. (B) α-m5HT signiﬁcantly increased the membrane potential
threshold required to generate an action potential in BLA principal neurons.
*P < 0.01, paired t -test, n = 8. (C) α-m5HT caused a modest but
signiﬁcant hyperpolarization of the resting membrane potential. *P < 0.05,
paired t -test. (D) α-m5HT did not alter the membrane response to a
hyperpolarizing current injection.
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to better deﬁne potential neurophysiological mechanisms confer-
ring the behavioral effects of intra-BLA α-m5HT. We speciﬁcally
examined the effects of α-m5HT on BLA population spike/ﬁeld
EPSPs in vitrowhere it potently reduced PS-EPSP slope and ampli-
tude. This effect was blocked by the 5-HT2 receptor antagonist
ketanserin. α-m5HT and ketanserin are relatively selective for rat
5-HT2 receptors over other kinds of serotonin receptors and 5-
HT2B receptors are not abundant in the central nervous system
(Pompeiano et al., 1994). Although ketanserin has modest afﬁnity
for α1 adrenergic and histamine H1 receptors, our combined data
are most consistent with the involvement of 5-HT2A or 5-HT2C
receptors in the modulation of BLA synaptic responses. As for the
speciﬁc neural mechanisms that might be involved, prior studies
have shown that α-m5HTdepolarizes parvalbumin-positive local
interneurons and stimulates spontaneous GABAergic neurotrans-
mission onto the BLA principal glutamatergic projection neurons
(Rainnie, 1999; Jiang et al., 2009). This suggested to us that 5-
HT2A/C-stimulated release of GABAand subsequent activation of
principal neuron GABA receptors might be a primary mechanism
for any behavioral effects of intra-BLA α-m5HT microinjec-
tion. However, α-m5HT modulation of the BLA PS-EPSP was
not dramatically attenuated by the GABAA receptor antagonist
bicuculline. One possible explanation is that α-m5HT-facilitated
release of GABA may be robust enough to activate inhibitory
GABAB receptors which can hyperpolarize principal neurons
directly (Washburn and Moises, 1992) or can act as presynaptic
heteroreceptors to suppress release from glutamatergic afferents
(Pan et al., 2009). GABAB receptor activation at either cellular
site would be sufﬁcient to suppress the PS-EPSP measured in this
study. Alternatively, 5-HT2 modulation of GABAergic interneu-
rons may not be well represented in peak and slope portions
of the BLA fEPSP. Previous work in the BLA has demonstrated
5-HT2 facilitation of spontaneous GABAergic synaptic activity
(Rainnie, 1999; Jiang et al., 2009), and these events are dominated
byperisomatic GABAergic synapses arising from feedback-type
interneurons scattered throughout the brain region (McDonald,
1985; Silberman et al., 2010; Diaz et al., 2011). These feedback
interneurons would not be strongly activated by a focal electrical
stimulus like the kind we used to evoke the ﬁeld EPSP. Rather,
their synchronized activation would tend to occur after principal
neuron activation during an experimentally evoked response. This
synaptic architecture combined with the type of electrophysiolog-
ical measures we used would under-represent any contributions
by feed-back GABAergic interneurons in our measures. It is likely
then that 5-HT2 facilitation of GABAergic mechanisms and direct
inhibition of principal neuron excitability would both contribute
to the behavioral pharmacology of intra-BLA α-m5HT. In this
context, it is also noteworthy that 5-HT2A receptors are not strictly
localized to GABAergic interneurons but are also expressed by
BLA principal neurons (Jiang et al., 2009; Bombardi, 2011). 5-
HT2C receptors are likewise expressed in the BLA (Li et al., 2004)
although their cellular distribution has not been as well studied.
Serotonin has complex direct effects on principal neuronmem-
brane potential that are mimicked by α-m5HT (Rainnie, 1999).
Thus α-m5HT modulation of the PS-EPSP may also be consis-
tent with direct modulation of principal neuron excitability by
5-HT2A/C receptors. We in fact found that α-m5HT reduced
BLA neuron excitability by increasing action potential threshold
and causing a small hyperpolarization of the resting membrane
potential consistent with previous ﬁndings (Rainnie, 1999). Fur-
ther,α-m5HTmodestly prolonged the action potential itself, which
might enhance the inactivation of voltage-gated sodium chan-
nels to further inhibit BLA neuron excitability. Unfortunately,
the molecular mechanisms mediating α-m5HT modulation of
BLA action potential threshold and membrane hyperpolarization
have yet to be established. And the intracellular signaling path-
ways engaged by Gq-coupled 5-HT2 receptors in the BLA have
not yet been characterized. 5-HT2 receptor-mediated activation
of various protein kinase signaling pathways are potential can-
didates. For example, PKC and PKA activity can inhibit neuron
excitability via inhibition of voltage-gated sodium channel func-
tion (Numann et al., 1991; Cantrell et al., 2002) and in the case
of PKC can increase action potential threshold (Dai et al., 2009).
Regardless, our ﬁndings are consistent with the hypothesis that
5-HT2 receptors directly modulate the excitability of BLA pyra-
midal neurons. This mechanism, along with robust activation of
GABAergic neurotransmission (Rainnie, 1999; Jiang et al., 2009),
helps explain the robust effects of α-m5HT on BLA extracellular
PS-EPSPs.
In summary, we have shown that microinjection of α-m5HT
dramatically modulates seeking-, and to a lesser extent
consumption-related, behaviors directed at a sweetened ethanol
solution. We speciﬁcally employed a self-administration paradigm
that procedurally separates seeking from consumption; and our
ﬁndings illustrate the important role played by BLA activity in
this self-administration paradigm. Our in vitro neurophysiology
investigations suggest that 5-HT2 modulation of BLA principal
neuron activity may be an important factor for these behavior
outcomes. Our results also highlight the growing list of behavioral
roles for BLA 5-HT2 receptors including the control of impulsive
actions (Hadamitzky and Koch, 2009), innate anxiety-like behav-
iors (Leite-Panissi et al., 2006), and conditioned fear-like behaviors
(Macedo et al., 2007). Future studies might employ 5-HT2A/C-
focused approaches to determine the relative contributions of
these speciﬁc behaviors to BLA-dependent reward-seeking.
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